dolutegravir rilpivirine | Dolutegravir / Rilpivirine - Patient

Keyword	CPC	PCC	Volume	Score	Length of keyword
dolutegravir rilpivirine	0.97	1	8849	47	24
dolutegravir	0.6	0.8	1226	12	12
rilpivirine	0.19	0.1	8164	59	11

Keyword	CPC	PCC	Volume	Score
dolutegravir rilpivirine	1.44	1	6168	91
dolutegravir rilpivirine brand name	1.67	0.6	9704	56
dolutegravir rilpivirine juluca	0.64	0.8	7703	44
dolutegravir rilpivirine 50 25 mg	0.06	1	2762	17
dolutegravir rilpivirine package insert	0.79	0.7	3984	79
dolutegravir and rilpivirine	1.39	0.1	6832	19
dolutegravir and rilpivirine tablets	1.62	0.1	8877	58
dolutegravir and rilpivirine combination	0.55	0.9	9550	56
dolutegravir + rilpivirine	1.41	0.7	2023	31
dolutegravir sodium brand name	1.99	0.8	2535	73
other name for dolutegravir	1.27	0.3	2301	77
dolutegravir lamivudine/tenofovir brand name	1.52	1	2859	62
dolutegravir 50mg/rilpivirine 25mg tab	0.14	0.9	250	60
dolutegravir-rilpivirine oral tablet 50-25 mg	0.51	0.6	7886	68
brand name for raltegravir	1.32	0.1	2887	62
abacavir/lamivudine dolutegravir brand name	0.53	0.4	3983	100
dolutegravir-rilpivirine 50-25 mg tab	1.13	0.7	5522	45
abacavir dolutegravir lamivudine brand name	0.47	0.1	158	24
tenofovir lamivudine/dolutegravir brand name	0.3	0.9	6488	57
dolutegravir tenofovir emtricitabine brand	1.4	0.8	5907	51
dolutegravir tablets for oral suspension	1.38	0.9	7873	96

Search Results related to dolutegravir rilpivirine on Search Engine

Dolutegravir / Rilpivirine - Patient | NIH - Clinicalinfo
hiv.gov

https://clinicalinfo.hiv.gov/en/drugs/dolutegravir-rilpivirine/patient

WEBDec 18, 2023 · Juluca contains two different medicines: dolutegravir and rilpivirine. For more information on the use of Juluca in adults with HIV, please refer to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Although Juluca is not FDA-approved for use in adolescents, it may be appropriate for use in certain adolescents.

DA: 76 PA: 3 MOZ Rank: 7 Up or Down: Up

Dolutegravir-Rilpivirine (Juluca) - National HIV Curriculum
uw.edu

https://www.hiv.uw.edu/page/treatment/drugs/dolutegravir-rilpivirine

WEB(dolutegravir and rilpivirine tablets) What is JULUCA? JULUCA is a prescription medicine that is used without other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults to replace their current anti-HIV-1 medicines when their healthcare provider determines that they meet certain requirements.

DA: 77 PA: 94 MOZ Rank: 6 Up or Down: Up

Dolutegravir and rilpivirine Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/dolutegravir-and-rilpivirine.html

WEBNov 13, 2022 · What is dolutegravir and rilpivirine? Dolutegravir and rilpivirine is a combination antiviral medicine used to treat HIV, the virus that can cause the acquired immunodeficiency syndrome (AIDS). dolutegravir and rilpivirine is not a cure for HIV or AIDS.

DA: 96 PA: 51 MOZ Rank: 60 Up or Down: Up

Dolutegravir/rilpivirine - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Dolutegravir/rilpivirine

WEBDolutegravir/rilpivirine, sold under the brand name Juluca, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It contains the medicines …

DA: 62 PA: 87 MOZ Rank: 15 Up or Down: Up

Dolutegravir And Rilpivirine (Oral Route) - Mayo Clinic
mayoclinic.org

https://www.mayoclinic.org/drugs-supplements/dolutegravir-and-rilpivirine-oral-route/description/drg-20406668

WEBDolutegravir and rilpivirine combination is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). It is given to patients to replace their current anti-HIV medicines when their healthcare provider determines that they meet certain requirements.

DA: 3 PA: 45 MOZ Rank: 32 Up or Down: Up

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220428/

WEBNov 2, 2018 · Dolutegravir/rilpivirine (DTG/RPV) was approved by the US Food and Drug Administration (FDA) as the first dual antiretroviral STR for the maintenance therapy of HIV-1 infection.

DA: 31 PA: 22 MOZ Rank: 49 Up or Down: Up

FDA approves first two-drug regimen for certain patients with HIV
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-two-drug-regimen-certain-patients-hiv

WEBJuluca is a fixed-dose tablet containing two previously approved drugs (dolutegravir and rilpivirine) to treat adults with HIV-1 infections whose virus is currently suppressed on a stable...

DA: 7 PA: 49 MOZ Rank: 98 Up or Down: Up

Dolutegravir plus rilpivirine: benefits beyond viral suppression
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276328/

WEBJun 6, 2022 · Dolutegravir (DTG) is a highly potent and effective INSTI that has become the gold standard treatment for naïve patients. [ 9 – 11 ] Dual therapy with DTG and lamivudine (3TC) or rilpivirine (RPV) has been approved for treatment-naïve (DTG/3TC) and experienced patients (DTG/3TC and DTG/RPV).

DA: 54 PA: 98 MOZ Rank: 87 Up or Down: Up

Clinical Review Report: Dolutegravir/Rilpivirine (Juluca)
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK536127/

WEBThe objective of this systematic review was to evaluate the beneficial and harmful effects of Juluca, a fixed-dose combination of dolutegravir (an INSTI) plus rilpivirine (an NNRTI), as a complete regimen to replace the current antiretroviral regimen for the treatment of HIV-1 infection in adults who are virologically stable and suppressed (HIV-...

DA: 59 PA: 64 MOZ Rank: 31 Up or Down: Up

dolutegravir-rilpivirine oral: Uses, Side Effects, Interactions ... - WebMD
webmd.com

https://www.webmd.com/drugs/2/drug-174446/dolutegravir-rilpivirine-oral/details

WEBDolutegravir/rilpivirine is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV...

DA: 14 PA: 33 MOZ Rank: 12 Up or Down: Up